418 related articles for article (PubMed ID: 22173164)
1. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
[TBL] [Abstract][Full Text] [Related]
2. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
[TBL] [Abstract][Full Text] [Related]
3. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia.
Shin HR; Oh JK; Masuyer E; Curado MP; Bouvard V; Fang Y; Wiangnon S; Sripa B; Hong ST
Asian Pac J Cancer Prev; 2010; 11(5):1159-66. PubMed ID: 21198257
[TBL] [Abstract][Full Text] [Related]
4. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.
Tyson GL; Ilyas JA; Duan Z; Green LK; Younes M; El-Serag HB; Davila JA
Dig Dis Sci; 2014 Dec; 59(12):3103-10. PubMed ID: 25204668
[TBL] [Abstract][Full Text] [Related]
5. Re: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
Matull WR; Khan SA; Pereira SP
J Natl Cancer Inst; 2007 Mar; 99(5):407; author reply 407-8. PubMed ID: 17341733
[No Abstract] [Full Text] [Related]
6. Impact of changes in the topographic classification of Klatskin tumor on incidence of intra- and extrahepatic bile duct cancer: A population-based national cancer registry study.
Kang MJ; Lim J; Han SS; Park HM; Kim SW; Won YJ; Park SJ
J Hepatobiliary Pancreat Sci; 2021 Sep; 28(9):740-750. PubMed ID: 33615747
[TBL] [Abstract][Full Text] [Related]
7. Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.
Ladep NG; Khan SA; Crossey MM; Thillainayagam AV; Taylor-Robinson SD; Toledano MB
World J Gastroenterol; 2014 Feb; 20(6):1544-53. PubMed ID: 24587630
[TBL] [Abstract][Full Text] [Related]
8. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.
Taylor-Robinson SD; Toledano MB; Arora S; Keegan TJ; Hargreaves S; Beck A; Khan SA; Elliott P; Thomas HC
Gut; 2001 Jun; 48(6):816-20. PubMed ID: 11358902
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma miscoding in hepatobiliary centres.
Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
[TBL] [Abstract][Full Text] [Related]
10. Histological classification of liver and intrahepatic bile duct cancers in SEER registries.
Altekruse SF; Devesa SS; Dickie LA; McGlynn KA; Kleiner DE
J Registry Manag; 2011; 38(4):201-5. PubMed ID: 23270094
[TBL] [Abstract][Full Text] [Related]
11. Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up!
Renzulli M; Brandi N; Brocchi S; Balacchi C; Lanza C; Pettinari I; Stefanini B; Carrafiello G; Piscaglia F; Golfieri R; Marasco G
J Anat; 2023 Apr; 242(4):683-694. PubMed ID: 36670522
[TBL] [Abstract][Full Text] [Related]
12. Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999-2010.
Polednak AP
J Registry Manag; 2013; 40(4):168-75. PubMed ID: 24625770
[TBL] [Abstract][Full Text] [Related]
13. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
14. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.
Al Mahjoub A; Bouvier V; Menahem B; Bazille C; Fohlen A; Alves A; Mulliri A; Launoy G; Lubrano J
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):678-684. PubMed ID: 30633038
[TBL] [Abstract][Full Text] [Related]
16. [Pathology of cholangiocarcinoma].
Guedj N; Bedossa P; Paradis V
Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
18. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.
West J; Wood H; Logan RF; Quinn M; Aithal GP
Br J Cancer; 2006 Jun; 94(11):1751-8. PubMed ID: 16736026
[TBL] [Abstract][Full Text] [Related]
19. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
20. Klatskin Tumor in the Light of ICD-O-3: A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (2001-2012).
Khan J; Ullah A; Matolo N; Waheed A; Nama N; Khan T; Tareen B; Khan Z; Singh SG; Cason FD
Cureus; 2021 Oct; 13(10):e18941. PubMed ID: 34815893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
